Development of Orodispersible Tablets of Candesartan Cilexetil-Β-Cyclodextrin Complex

Journal of Pharmaceutics
doi 10.1155/2013/583536
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Biorelevant Dissolution of Candesartan Cilexetil

ADMET and DMPK
PharmacologyHealthMedicineToxicologyChemistryPharmaceutics
2017English

Update on the Clinical Pharmacology of Candesartan Cilexetil

American Journal of Hypertension
Internal Medicine
2000English

Orodispersible Tablets: An Overview

MOJ Proteomics & Bioinformatics
2018English

Evaluation of the Pharmacokinetic Interaction Between Candesartan Cilexetil and Felodipine

Journal of Bioequivalence & Bioavailability
2011English

Anti-Fibrogenic Effects of Captopril and Candesartan Cilexetil on the Hepatic Fibrosis Development in Rat

Experimental and Toxicologic Pathology
MedicineForensic MedicinePathologyCell BiologyToxicology
2003English

Candesartan Cilexetil/Hydrochlorothiazide Combination Treatment Versus High-Dose Candesartan Cilexetil Monotherapy in Patients With Mild to Moderate Cardiovascular Risk (CHILI Triple T)

Vascular Health and Risk Management
2011English

The Popularization of Orodispersible Tablets in the Pharmaceutical Market

Infarma - Ciências Farmacêuticas
2018English

Design, Development and Formulation of Orodispersible Tablets of a Model Drug Using Response Surface Methodology

Pharmaceutica Analytica Acta
2012English

Effects of Candesartan Cilexetil on Urinary Protein Excretion in Patients With Essential Hypertension.

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy